Kronox Lab Sciences IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is important to Exercise Caution and Conduct Thorough Research Before Making Any Investment Decisions.
About Kronox Lab Sciences IPO-
How Much GMP Price Kronox Lab Sciences IPO today?, live Grey Market Premium Kostak Rates today live Kronox Lab Sciences IPO Now. Subject to sauda Rate today, Kronox Lab Sciences IPO as of today Subject to sauda rates kostak.
Kronox Lab Sciences IPO is to open on 3 June, 2024. Kronox Lab Sciences is a Mainline IPO to Raise 9,600,000 Shares (Rs. 130.56 Cr. Via IPO. The Kronox Lab Sciences IPO Price Band is Fixed At ₹129 to ₹136 Per Every Share With a IPO Lot Size of 110 Shares.
About Kronox Lab Sciences Data Like –
- Mr. Jogindersingh Jaswal is the CEO of Kronox Lab Sciences and Kronox Lab Sciences was founded in the year 2008 and has just completed 17 years in operation.
- Kronox Lab Sciences Manufacture High Purity Speciality Fine Chemicals For Diversified End-User Industries. Our Purity Speciality Fine Chemicals Are Used Mainly As (I) Reacting Agents And Raw Materials In The Manufacturing Of Active Pharmaceutical Ingredients (APIs); (Ii) Excipients In Pharmaceutical Formulations; (Iii) Reagents For Scientific Research And Laboratory Testing; (Iv) Ingredients In Nutraceuticals Formulations; (V) Process Intermediates And Fermenting Agents In Biotech Applications; (Vi) Ingredients In Agrochemical Formulations; (Vii) Ingredients In Personal Care Products; (Viii) Refining Agents In Metal Refineries; And (Ix) Ingredients In Animal Health Products, Amongst Others.
Kronox Lab Sciences IPO GMP With Per Lot Profit
| DATE | IPO GMP PRICE | EST LISTING PRICE |
|---|---|---|
| 10 June | ₹32 | ₹168 |
| 9 June | ₹32 | ₹168 |
| 8 June | ₹32 | ₹168 |
| 7 June | ₹35 | ₹171 |
| 6 June | ₹42 | ₹178 |
| 5 June | ₹42 | ₹178 |
| 4 June | ₹50 | ₹186 |
| 3 June | ₹82 | ₹218 |
| 2 June | ₹82 | ₹218 |
| 1 June | ₹82 | ₹218 |
| 31 May | ₹82 | ₹218 |
| 30 May | ₹82 | ₹218 |
| 29 May | ₹82 | ₹218 |
| 28 May | ₹0 | ₹136 |
Also Read : Kronox Lab Sciences IPO Details Today, GMP Price, Date, Review
Latest IPO GMP
We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.
IPO Grey Market Premium (GMP)
Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Kronox Lab Sciences IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Kronox Lab Sciences IPO or not and not by looking at the GMP price of the IPO.
Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.
Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.
Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.
